ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

Also Senate approves spending bill.

January 23, 2004